Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants
Clinical trial NCT04909242 · COMPLETED
Trial details
- NCT number
- NCT04909242
- Sponsor
- Dizal Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2022-02-07
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.